NEW YORK (GenomeWeb News) - The Canadian company BiOasis Technologies has appointed Leigh Anderson to its scientific advisory board. Anderson is founder and CEO of the Plasma Proteome Institute and he served as CSO at Large Scale Biology Corporation. He serves on the advisory board of the UVic-Genome BC Proteomics Center and Better Biomarkers of Acute and Chronic Allograft Rejection, a Genome Canada Initiative for Human Health program.
 

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.

A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.

The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.

In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.